ERS Virtual International Congress 2021 - Pro-Con debate Post COVID interstitial lung diseases syndrome: diagnosis and management as interstitial lung disease?

Interstitial lung diseases

Pro-Con debate

Post COVID interstitial lung diseases syndrome: diagnosis and management as interstitial lung disease? Clinical

Aims : To describe the spectrum of interstitial lung changes observed after COVID-19 infection, and to address diagnostic and management related issues; to debate the use or not corticosteroids plus antifibrotics and/or immunomodulation according pathogenetic and clinical/radiological insights in the field. to discuss clinical, radiological and pathological description of post COVID-19 interstitial lung cases.

Target audience : Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Medical Student, Patient, Physician in Pulmonary Training, Physiologist, Journalist

Methods : Cell and molecular biology, Imaging, Physiology

Chairs

Heraklion (Greece)

Mainz (Germany)

11:15

Introduction

220

11:17

Use of antifibrotics in post-COVID ILD: PRO B. Crestani(Paris, France) -

221

11:29

Use of antifibrotics in post-COVID ILD: CON S. Tomassetti(Florence, Italy) -

222

11:41

Discussion and Q&A

223